Immuno- and Bio-therapies

Overview

Biotherapeutics for cancer treatment uses viruses to kill cancer cells while sparing healthy ones. There is a potential for oncolytic viruses to be developed into vaccines for the treatment of cancer. The Immuno- and Bio-therapies Program is identifying new agents that can selectively destroy cancer cells and minimize the adverse effects experienced by patients receiving current treatments.

Lead Principal Investigator

Dr. John Bell
Program Director, Immuno- and Bio-therapies